US Patent Issued to Changchun Genescience Pharmaceutical on March 25 for "Humanized anti-A Beta monoclonal antibody and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,386, issued on March 25, was assigned to Changchun Genescience Pharmaceutical Co. Ltd. (Jilin, China).

"Humanized anti-A Beta monoclonal antibody and application thereof" was invented by Xiao Feng (Changchun, China), Yangqiu Liang (Changchun, China), Lei Jin (Changchun, China), Dawei Sun (Changchun, China), Tao Wang (Changchun, China), Liang Xiao (Changchun, China), Shuang Liu (Changchun, China), Yuheng Chen (Changchun, China) and Zhengyi Li (Changchun, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a humanized anti-ABeta monoclonal antibody and use thereof. The humanized anti-ABeta monoclonal antibody provided can inhibit the po...